Rocket Pharmaceuticals, Inc. (RCKT) Institutional Ownership

Institutions by Trading Activity

111,848,889Shares Outstanding

210Shares held by institutions

$783Value of institutional holdings

0.09%Institutional ownership %

14.06%Shares Changed QoQ

5No. of institutional investors

Recent 13F filings as of December 2025 show that 5 institutional investors hold a position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT).

Rocket Pharmaceuticals saw its institutional ownership percentage fell to 0.1% in December 2025 from 86.5% in September 2025.
The company experienced a 14.06% quarterly change in institutional shares held, alongside a decrease of 97.75% in total owners annually.
The latest 13F cycle for Rocket Pharmaceuticals reveals that of 5 total investors, 3 funds grew their exposure, whereas 1 reduced theirs and 1 made no changes.
The aggregate institutional position in Rocket Pharmaceuticals now stands at 97.39K shares as of December 2025, after investors increased their holdings (up by 12.01K shares quarter on quarter which is down 110.07Mn shares year over year).
With 63.75K shares, SG Americas Securities, LLC commands the largest institutional position in Rocket Pharmaceuticals as of December 31, 2025, equating to 0.06% of the company.
Among the most significant buyers of Rocket Pharmaceuticals during December 2025 were SG Americas Securities, LLC (15.02K), MassMutual Private Wealth & Trust, FSB (199), GAMMA Investing LLC (91).
Leading sellers of Rocket Pharmaceuticals stock in December 2025 included Assenagon Asset Management S.A. (3.30K).
The top 5 institutional holders of Rocket Pharmaceuticals for the quarter ending December 2025 included SG Americas Securities, LLC (63.75K), Assenagon Asset Management S.A. (32.52K), MassMutual Private Wealth & Trust, FSB (825), True Wealth Design, LLC (210), GAMMA Investing LLC (91).

210 Total Shares Held

Rows:

Owner Name	Date	Shares Held	Change (QoQ)	Change (%)	Value (USD)
RTW INVESTMENTS, LP	30 Sep, 2025	17,687,772	0	0.00%	$57,662,137.00
MAVERICK CAPITAL LTD	30 Sep, 2025	8,468,344	104,531	1.25%	$27,606,801.00
BlackRock, Inc.	30 Sep, 2025	7,114,371	-314,305	-4.23%	$23,192,850.00
VANGUARD GROUP INC	30 Sep, 2025	6,892,204	769,743	12.57%	$22,468,585.00
MPM BioImpact LLC	30 Sep, 2025	3,903,381	300	0.01%	$12,725,022.00
SUVRETTA CAPITAL MANAGEMENT, LLC	30 Sep, 2025	3,843,333	-300,000	-7.24%	$12,529,266.00
MORGAN STANLEY	30 Sep, 2025	3,647,039	478,003	15.08%	$11,889,347.00
MILLENNIUM MANAGEMENT LLC	30 Sep, 2025	3,570,391	1,221,554	52.01%	$11,639,475.00
Monaco Asset Management SAM	30 Sep, 2025	2,892,261	2,439,494	538.80%	$9,428,771.00
Newtyn Management, LLC	30 Sep, 2025	2,502,863	502,863	25.14%	$8,159,333.00
D. E. Shaw & Co., Inc.	30 Sep, 2025	2,189,750	1,196,925	120.56%	$7,138,585.00
JPMORGAN CHASE & CO	30 Sep, 2025	2,097,033	889,231	73.62%	$6,836,329.00
GEODE CAPITAL MANAGEMENT, LLC	30 Sep, 2025	1,914,554	-116,337	-5.73%	$6,242,766.00
TWO SIGMA ADVISERS, LP	30 Sep, 2025	1,795,751	305,500	20.50%	$5,854,148.00
STATE STREET CORP	30 Sep, 2025	1,745,310	-198,380	-10.21%	$5,689,711.00
CITADEL ADVISORS LLC	30 Sep, 2025	1,670,927	1,670,927	0.00%	$5,447,222.00
TWO SIGMA INVESTMENTS, LP	30 Sep, 2025	1,609,682	-115,678	-6.70%	$5,247,563.00
BALYASNY ASSET MANAGEMENT L.P.	30 Sep, 2025	1,313,737	1,181,931	896.72%	$4,282,783.00
GOLDMAN SACHS GROUP INC	30 Sep, 2025	1,271,093	-304,375	-19.32%	$4,143,763.00
Prosight Management, LP	30 Sep, 2025	1,267,965	-312,623	-19.78%	$4,133,566.00

1 - 20 of 173